Fix the README license link to use its full GitHub URL, since LICENSE.md is not included in the CRAN source package. Enable file-URI checks in CI.
Use DOI markup in help-page references as required by CRAN incoming checks.
Disable RStudio editor integration when generating coverage reports so the GitHub Actions coverage job does not require rstudioapi.
Add GitHub Actions line-coverage reports for both test suites, with downloadable uncovered-line reports and optional Codecov uploads.
Add grouped testthat tests for common trial designs, survival moments and regional ATE estimation, alongside the existing regression suite.
Label consistency and design help-page titles by Method I or Method II, and remove print-method arguments from the regional ATE help page.
Use complete Chicago author-date references in the README and help pages, including all authors, journal volume and issue, article identifiers and DOIs.
Expand the regional ATE README guide with participant-level data, model options, and executable examples comparing estimation before and after source screening.
Add GitHub Actions checks on push and pull requests for Windows, macOS and Linux, including R-devel and the previous R release. The Linux R-release job also compiles the PDF manual; successful check logs are retained.
Prepare the first CRAN submission: adopt the MIT license, add structured author metadata and method references, and update the maintainer email to kunhaiq@stu.ecnu.edu.cn.
Correct binary Method II arm allocation for unequal randomization, use actual arm sizes in Wald standard errors, include zero regional effects, and estimate conditional CP using observed overall successes. Return simulation diagnostics and regional arm sizes. Zero-variance samples are handled without division by zero.
Accept the default continuous response type in both Method II functions.
Use continuous design sample sizes consistently inside
theoretical CP formulas; return rounded overall sample size
recommendations separately. conProb2() and random-effect CP
values may change slightly. regFrac2() remains a
scalar-returning solver for the symmetric design, not a general
unconstrained optimizer.
Allow different continuous control means in
conProbII2() via trailing muCtrl1 and
muCtrl2 arguments, preserving earlier positional
arguments.
Share design validation and random-effect root finding. Search beyond the old [1, 100000] bracket, handle small roots, and distinguish infeasibility from invalid inputs. Errors now raise conditions rather than returning unnamed message lists.
Preserve internal precision for Bernoulli and PH moments and CP outputs.
Correct uniform censoring survival before its lower limit for NPH RMST variance. Require the RMST horizon to be strictly below the censoring upper limit.
Correct CPlbd() regional sample sizes (remove the
erroneous inverse-fraction factor); return numeric NA for unavailable
counts. The fr argument remains accepted for compatibility
and regional vector sizing.
Fix supplied propensity vectors in regATE_dr(),
subset treatment propensity vectors during source selection, re-estimate
region propensity when the retained population changes, and handle
target-only estimation explicitly.
Add regression tests against published benchmarks, exact binomial probabilities, no-censoring RMST moments, and Ren et al. (2026) random-effects identities and simulation.
Simplify public roxygen documentation, explain parameter conventions and returned counts, distinguish continuous-design CP from rounded recommendations, and clarify source-screening assumptions and uncertainty in regional ATE estimation.
Return exact full-region Method I CP in the degenerate two-trial case, and avoid numerical overflow in piecewise-hazard RMST integration and small-heterogeneity lower-bound equality counts.
Validate ATE settings, target labels and covariates, and reject undefined nuisance predictions and weights with explicit errors.
Remove the unused cubature dependency.
Rewrite the README with a function guide and executable design examples; clarify CP conditioning, symmetric fraction selection, and overall versus regional counts.
Verify two-trial Method I and II formulas against independent normal simulations with unequal powers, variances, regional fractions and randomization ratios.